期刊文献+

血清降钙素原检验在呼吸系统感染治疗中的临床价值 被引量:20

Clinical value of serum rrocalcitonin levels test on respiratory system infection
原文传递
导出
摘要 目的 研究血清降钙素原水平检验在呼吸系统感染治疗中的临床意义.方法 选择呼吸系统感染患者80例作为观察组,根据患者感染严重程度将观察组分为普通感染组(40例)和严重感染组(40例).另选取同期健康志愿者40例为对照组.比较三组呼吸系统感染严重程度与APACHE-Ⅱ评分及血清降钙素原的关系、治疗前后血清降钙素原的变化.结果 对照组、普通感染组、严重感染组患者血清降钙素原水平分别为(0.34±0.06)、(17.54±6.01)、(68.51±13.42)μg/L,APACHE-Ⅱ评分分别为0、(3.22±1.92)、(24.45±6.32)分.严重感染组患者血清降钙素原水平明显高于普通感染组和对照组,组间比较差异有统计学意义(t =3.35,3.48,P均<0.05);普通感染组患者血清降钙素原水平明显高于对照组,组间比较差异有统计学意义(t =3.26,P<0.05).严重感染组患者APACHE-Ⅱ评分明显高于普通感染组,组间比较差异有统计学意义(t =3.67,P<0.05).呼吸系统感染患者血清降钙素原水平及APACHE-Ⅱ评分均随患者感染程度的增加而升高,两者呈正相关(t =3.52,3.47,P<0.05).观察组患者治疗前及治疗后与对照组患者血清降钙素原水平比较差异有统计学意义(t=3.58,3.41,P<0.05),观察组患者治疗前血清降钙素原水平与治疗后及对照组比较,差异有统计学意义(t=3.50,3.49,P<0.05).结论 血清降钙素原水平与呼吸系统感染程度呈正比,可用于判断患者治疗的临床疗效及预后情况,对呼吸系统感染的治疗具有指导作用. Objective To study the clinical significance of the serum procalcitonin levels test in the treatment of respiratory system infection.Methods Chose 80 cases patients with respiratory system infection as the research object,for the observation group,according to the severity of infection in patients with the observation group was divided into general infection group(40 cases) and severe infection group (40 cases).Healthy volunteers were selected for the control group of 40 cases.Compared the three groups of patients with respiratory system infection and the severity of APACHE-Ⅱ score and serum calcitonin,before and after the treatment of the relationship between the changes of serum procalcitonin.Results In the control group,the common infection group,severe infection serum procalcitonin levels were(0.34 ±0.06),(17.54 ± 6.01),(68.51 ± 13.42) μg/L,APACHE-Ⅱ score was 0 points,(3.22 ± 1.92),(24.45 ±6.32) points.Severe infection serum procalcitonin levels were significantly higher than the general infection group and control group,there was significant difference between the two groups (t =3.35,3.48,P 〈 0.05) ; Serum group were general infection procalcitonin levels,were significantly higher than those in the control group,significant differences also exist between the two groups(t =3.26,P 〈 0.05).Serious infection group were significantly higher than in the general score of APACHE-Ⅱ infection group,there was significant difference between the two groups (t =3.67,P 〈 0.05).Procalcitonin levels and APACHE-Ⅱ score increased with the increased degree of infection in patients with increased in serum of patients with respiratory system infection,they were positively correlated (t =3.52,3.47,P 〈 0.05).Compared with the observation group patients before and after treatment,the serum procalcitonin levels in control group were significant different(t =3.58,3.41,P 〈0.05),the patients in observation group before treatment,the levels of serum procalcitonin and after treatment and the control group,the difference had statistical significance(t =3.50,3.49,P 〈0.05).Conclusions The levels of serum procalcitonin and respiratory infection is proportional to the degree,it can be used to judge the clinical curative effect and the prognosis of patients,and has a guiding role for the treatment of respiratory infection.
作者 张颖颖
出处 《中国实用医刊》 2015年第6期54-56,共3页 Chinese Journal of Practical Medicine
关键词 血清降钙素原 检验 呼吸系统感染 APACHE-Ⅱ评分 Serum procalcitonin Inspection Respiratory infection APACHE-Ⅱ score
  • 相关文献

参考文献16

二级参考文献112

共引文献565

同被引文献130

  • 1张宗新.降钙素原在细菌感染性疾病诊断中的应用探讨[J].检验医学,2006,21(2):117-119. 被引量:59
  • 2Savar,Nastaran Sadat,Jahanian-Najafabadi,et al.In silico and in vivo studies of truncated forms of flagellin(FliC)of enteroaggrega- tive Escherichia coll fused to FimH from uropathrenic Escherichia coli as a vaccine candidate against urinary tract infections[J].Journal of Biotechnology,2014,175;31-37.
  • 3Pieri G, Agarwal B, Burroughs AK.C-reactive protein and bacterial infection in cirrhosis[J].Ann Gastroenterol ,2014,27(2):113-120.
  • 4Foushee JA,Hope NH,Grace EE.Applying biomarkers to clinical practice :a guide for utilizing procalcitonin assays[J]. J Antimicrob Chemother,2012,61(17):2560-2569.
  • 5Bouadraa L1Luyt CE1Tubach F,et al.Use of procalci- tonin to reduce patients' exposure to antibiotics in inten- sive care units(PRORATA trial):a multicentre randomised controlled trial[J].Lancet,2010,375(9713):463-474.
  • 6Dellinger RP,Levy MM,Rhodes A,et al.Surviving Sep- sis Campaign: international guidelines for management of severe sepsis and septic shock,2012[J], Intensive Care Med,2013,39(2):165-228.
  • 7倪语星,尚红.临床微生物学与检验.第4版.北京:人民卫生出版社,2008:567.
  • 8赵益敏.联合降钙素原和细菌培养在尿路感染中的应用价值.医学前沿,2014(33):221-222.
  • 9Becker KL, Nylen ES, White JC, et al. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. Clin Endocrinol Metab, 2004, 89(4): 1512-1525.
  • 10Gaini S, Koldkjer OG, Moller HJ, et al. A comparison of high- mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-aquired infections and bacteraemia: a prospective study. Grit Care, 2007, 11(4):77-87.

引证文献20

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部